Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
59-291 Section 3, Lecture 2 Diuretics: -increase in Na+ excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect against osteoporosis Loop diuretics -used in patients with poor kidney function where thiazide derivatives will not be effective 1 vasodilators b-antagonists a-antagonists Angiotensin II receptor antagonists b-antagonists CNS-directed sympatholytics b-antagonists ACE inhibitors Angiotensin II receptor antagonists diuretics 2 Potassium-Sparing Diuretics -mild diuretic and antihypertensive effect -Minimize renal-K+ loss thus preventing hypokalemia -If the patient can’t tolerate these drugs then use thiazide and take KCl tablets Drug Classification Common Adverse Effects Common Drug Interactions Thiazide and loop diuretics Blood cell deficiencies, hyperlipidemia, hyperuricemia, hypokalemia, and other electrolyte changes Aggravation of diabetes Increase serum levels of lithium. Hypotensive effect decreased by NSAIDs and augmented by ACE inhibitors Potassium-sparing diuretics Hyperkalemia Hyperkalemic effect increased by ACE inhibitors and potassium supplements Diuretics 3 Sympatholytics Drug Classification Common Adverse Effects Common Drug Interactions Adrenergic receptor antagonists α-Adrenergic receptor antagonists Dizziness, first-dose syncope, fluid retention, and orthostatic hypotension Hypotensive effect increased by β-adrenergic receptor antagonists and diuretics β-Adrenergic receptor antagonists Bradycardia, bronchoconstriction, depression, fatigue, impaired glycogenolysis, and vivid dreams Cardiac depression increased by diltiazem and verapamil. Hypotensive effect decreased by NSAIDs Centrally acting drugs Clonidine Dry mouth, fatigue, rebound hypertension, and sedation Hypotensive effect decreased by tricyclic antidepressants Sedative effect increased by CNS depressants Guanabenz Same as clonidine Same as clonidine Guanfacine Same as clonidine but milder Same as clonidine Methyldopa Autoimmune hemolytic anemia, hepatitis, and lupuslike syndrome. Other adverse effects same as those of clonidine Hypotensive effect increased by levodopa. Other interactions same as those of clonidine 4 vasodilators b-antagonists a-antagonists Angiotensin II receptor antagonists b-antagonists CNS-directed sympatholytics b-antagonists ACE inhibitors Angiotensin II receptor antagonists diuretics 5 Angiotensin Inhibitors Drug Oral Bioavailabili ty Absorption Reduced by Food Active Metabolite Duration of Action (Hours) Angiotensin-converting enzyme inhibitors Benazepril 37% No Benazeprilat 24 Captopril 75% 30-40% None Enalapril 60% No Enalaprilat* 24 Fosinopril 36% No Fosinoprilat 24 Lisinopril 25% No None 24 Quinapril 60% 25-30% Quinaprilat 24 Ramipril 55% No Ramiprilat 24 Losartan 33% 10% Carboxylic acid metabolite 24 Valsartan 25% 40% None 24 Candesartan 15% No None 24 12-Jun Angiotensin receptor antagonists 6 Angiotensin inhibitors 1. ACE inhibitors 2. Angiotensin receptor inhibitors Renin secretion induced by: 1-Symp. Outflow 2-reduction in BP and wall tension in renal arterioles 3-reduced NaCl reabsorbtion AT1 AT1 G-proteins – IP3 7 ACE inhibitors Adverse effects • Increase fetal morbidity and mortality, especially during 2nd and 3th trimesters • Renal failure in patients with bilateral renal artery stenosis 8 Drug Classification Common Adverse Effects Common Drug Interactions Angiotensin inhibitors Angiotensin-converting enzyme (ACE) inhibitors Acute renal failure, angioedema, cough, hyperkalemia, loss of taste, neutropenia, and rash Increase serum levels of lithium. Hyperkalemic effect increased by potassiumsparing diuretics and potassium supplements. Hypotensive effect decreased by NSAIDs Angiotensin receptor antagonists Hyperkalemia Serum levels of drug increased by cimetidine and decreased by phenobarbital 9 Vasodilators • Organic nitrites and nitrates – Amyl nitrites; (nitrites), administered by inhalation – Nitroglycerin (glyceryl trinitrate); sublingual, oral or transdermal administration • Calcium channel blockers – Amlodipine, felodipine – Diltiazem, verapamil 10 Tolerance Aldehyde dehydrogenase releases NO from nitroglycerin, and this process is accompanied with formation of superoxide anion free radical (O2-) that in turn, deactivate aldehyde dehydrogenase -to avoid periodically interrupt the administration of the drugs Pills –sublingual Sustained release- patches, skin ointments, IV Adverse effects- headaches, hypotension, dizziness, reflex tachycardia, use b-blocker in combination 11 Ca2+- channel blockers (CCBs) Suppress cardiac activity and relax smooth muscles-in combination increase coronary blood flow Side effects: fatigue, headache, dizziness, flushing, peripheral edema Occasionally cause gingival hyperplasia 12 Selection of Antihypertensive Drugs for Patients with Specific Traits or Concurrent Diseases Patient Characteristic Most Preferred Drugs Least Preferred Drugs Age over 65 years Diuretic, ACEI, CCB Centrally acting α2 agonist African heritage Diuretic, CCB β-blocker Pregnant Methyldopa, labetalol ACEI, ARB Angina pectoris β-blocker, CCB Hydralazine, minoxidil Myocardial infarction β-blocker, ACEI, aldosterone antagonist Congestive heart failure Diuretic, ACEI, ARB, β-blocker Recurrent stroke prevention Diuretic, ACEI, ARB Chronic kidney disease ACEI, ARB Diabetes Diuretic, ACEI, ARB, β-blocker, CCB Asthma CCB, ACEI Benign prostatic hyperplasia α-blocker Migraine headache β-blocker, CCB Osteoporosis Diuretic β-blocker 13